Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00267098 · ClinicalTrials.gov registry record · NA
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
A NA study, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- NA
- Development phase
- 918
- Enrollment target
NCT00267098 is a NA study that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 918 participants.
The verdict
NCT00267098, a NA study, has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- NA
- Development phase
- 918 participants
- Enrollment target
Study Summary
Heart failure is a progressive disease that decreases the pumping action of the heart. This may cause a backup of fluid in the heart and may result in heart beat changes. When there are changes in the heartbeat, sometimes a pacemaker is used to control the rate and rhythm of the heartbeat. In this trial, the researchers will test if pacing both the left and right lower half of the heart (ventricles) will: * decrease the number of hospital and clinic visits due to heart failure symptoms * extend life * delay heart failure symptoms as compared to those who are paced in only one ventricle (the right ventricle)
Interventions
- DEVICE Cardiac Resynchronization Therapy (CRT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 918 participants |
| Start Date | 2003-12 |
| Est. Completion | 2013-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00267098
The ClinicalTrials.gov registry entry for NCT00267098 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 918 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cardiac Resynchronization Therapy (CRT) is the first listed.
NCT00267098 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00267098 about?
NCT00267098 is a clinical study titled "Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)". Heart failure is a progressive disease that decreases the pumping action of the heart. This may cause a backup of fluid in the heart and may result in heart beat changes. When there are changes in the heartbeat, sometimes a pacemaker is used to control the rate and rhythm of the heartbeat. In this t...
What is the current status of trial NCT00267098?
This trial is currently completed. It is a NA study. The enrollment target is 918 participants. The study started on 2003-12. Estimated completion is 2013-03.
What interventions are being tested in trial NCT00267098?
The interventions under investigation include: Cardiac Resynchronization Therapy (CRT) (DEVICE).
Who is sponsoring clinical trial NCT00267098?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.